Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Surgery Partners (SGRY) Revenue (2016 - 2025)

Surgery Partners (SGRY) has disclosed Revenue for 12 consecutive years, with $885.0 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 2.38% to $885.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.3 billion through Dec 2025, up 6.24% year-over-year, with the annual reading at $3.3 billion for FY2025, 6.24% up from the prior year.
  • Revenue hit $885.0 million in Q4 2025 for Surgery Partners, up from $821.5 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $885.0 million in Q4 2025 to a low of $512.4 million in Q1 2021.
  • Historically, Revenue has averaged $696.5 million across 5 years, with a median of $690.6 million in 2022.
  • Biggest five-year swings in Revenue: skyrocketed 45.0% in 2021 and later rose 2.38% in 2025.
  • Year by year, Revenue stood at $610.2 million in 2021, then grew by 15.88% to $707.1 million in 2022, then increased by 4.0% to $735.4 million in 2023, then increased by 17.54% to $864.4 million in 2024, then rose by 2.38% to $885.0 million in 2025.
  • Business Quant data shows Revenue for SGRY at $885.0 million in Q4 2025, $821.5 million in Q3 2025, and $826.2 million in Q2 2025.